Osteo D 1ml

Breastfed infants who are not exposed to sunlight are unlikely to obtain adequate amounts of vitamin D from breast milk to satisfy their needs beyond early infancy because the vitamin D content of human milk is low (1-10 IU/250 mL). The vitamin D available to the infant during the first 6 months of life depends initially on the vitamin D status of the mother during pregnancy and later on the infant\\\\\\\\\\\\\\\’s diet and exposure to sunlight.

Vitamin D deficiency can result in rickets, a painful disease characterized by a softening of the bones and the growth plates. Dietary vitamin D is therefore recommended to correct for a lack of exposure to ultraviolet light fulfilling the required amount of Vitamin D.

Also, while the importance of vitamin D in infancy has been focused on protection from rickets, emerging research suggests that optimal vitamin D status may play a role in the protection against the development of other diseases.

Vitamin D is also important for the normal growth of the children and it helps to prevent rickets.

Oral solution:
Colecalciferol (Vitamin D3) is recommended 5-10 mcg or 1-2ml (200-400 IU)/day or as directed by the physician.

Chewable tablet:
Cholecalciferol (Vitamin D3) is recommended 100 IU (1 tablet) daily, or as directed by physician. Take the medicine with food or within 1 hour after a meal. Place the tablet in mouth swallow after chewing.

Generally all nutritional supplements are considered to be safe and well tolerable. However, few side-effects can generally occur including hypercalcaemia syndrome or Calcium intoxication (depending on the severity and duration of hypercalcaemia), occasional acute symptoms include anorexia, headache, nausea, vomiting, abdominal pain or stomach ache and constipation with the administration of Colecaciferol.

There is no evidence to suggest that vitamin D is teratogenic in humans even at very high doses. Colecalciferol should be used during pregnancy only if the benefits outweigh the potential risk to the fetus.

It should be assumed that exogenous Colecalciferol passes into the breast milk. In view of the potential for hypercalcaemia in the mother and for adverse reactions from Colecalciferol in nursing infants, mothers may breastfeed while taking Colecalciferol, provided that the serum Calcium levels of the mother and infant are monitored.